Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Laureate Biopharmaceutical ServicesLaureate Biopharmaceutical Services
VS
BioconBiocon
Laureate Biopharmaceutical Services

Laureate Biopharmaceutical Services

N/A

Last Update: 09/01/2026

View Profile
Between 700 and 749
http://www.Patheon.com
748/1000Moderate

September 30, 2014 - Gallus BioPharmaceuticals, LLC has been acquired by DPx Holdings B.V., privately owned by JLL Partners and Royal DSM and the parent company of Patheon. Patheon’s biologic drug substance business, a unit of DPx Holdings, now spans four global facili...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:5
Subsidiaries:13
12-month incidents
0
Known data breaches
0
Attack type number
0
Biocon

Biocon

Hosur Road, Electronics City, Bangalore, Karnataka, IN, 560100

Last Update: 12/09/2026

View Profile
Between 750 and 799
http://www.biocon.com
773/1000Fair

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:11,558
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Laureate Biopharmaceutical Services

Laureate Biopharmaceutical Services

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Biocon

Biocon

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Laureate Biopharmaceutical Services in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Biocon in 2026.

Incidents

Incident History - Laureate Biopharmaceutical Services (X = Date, Y = Severity)

Laureate Biopharmaceutical Services cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Biocon (X = Date, Y = Severity)

Biocon cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Laureate Biopharmaceutical Services

Laureate Biopharmaceutical Services

Incidents
No explicit notable incidents reported.
Biocon

Biocon

Incidents
No explicit notable incidents reported.

FAQ

Between Laureate Biopharmaceutical Services company and Biocon company, which one has the best AI Cybersecurity Score ?
Between Laureate Biopharmaceutical Services company and Biocon company, which one has experienced more cyber incidents in the past ?
Between Laureate Biopharmaceutical Services company and Biocon company, which one has experienced more cyber incidents this year ?
Between Laureate Biopharmaceutical Services company and Biocon company, which one has experienced at least one ransomware attack ?
Between Laureate Biopharmaceutical Services company and Biocon company, which one has experienced at least one data breach ?
Between Laureate Biopharmaceutical Services company and Biocon company, which one has experienced at least one targeted cyberattack ?
Between Laureate Biopharmaceutical Services company and Biocon company, which one has experienced at least one vulnerability ?
Between Laureate Biopharmaceutical Services company and Biocon company, which one holds the most compliance certifications ?
Between Laureate Biopharmaceutical Services company and Biocon company, which one holds the fewest compliance certifications ?
Between Laureate Biopharmaceutical Services company and Biocon company, which one has the most subsidiaries ?
Between Laureate Biopharmaceutical Services company and Biocon company, which one has the largest number of employees ?
Between Laureate Biopharmaceutical Services and Biocon, which company holds both SOC 2 Type 1 certifications ?
Between Laureate Biopharmaceutical Services and Biocon, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Laureate Biopharmaceutical Services or Biocon ?
Which company is PCI DSS compliant - Laureate Biopharmaceutical Services or Biocon ?
Between Laureate Biopharmaceutical Services and Biocon, which company complies with HIPAA regulations for healthcare data ?
Between Laureate Biopharmaceutical Services and Biocon, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-96451
SUMMARY

Authorization Bypass Through User-Controlled Key vulnerability in Ultimate Member Ultimate Member ultimate-member allows Privilege Escalation.This issue affects Ultimate Member: from n/a through 2.13.1.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-103342
SUMMARY

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Unlimited Elements Unlimited Elements For Elementor (Free Widgets, Addons, Templates) unlimited-elements-for-elementor allows Reflected XSS.This issue affects Unlimited Elements For Elementor (Free Widgets, Addons, Templates): from n/a through 2.0.20.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 7.1)
CVSS3
Base Score: 7.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
IMPACT SCORE
3.7
EXPLOITABILITY
2.8
CVE-2026-103065
SUMMARY

Improper Validation of Specified Quantity in Input vulnerability in Themeum Kirki kirki allows Accessing Functionality Not Properly Constrained by ACLs.This issue affects Kirki: from n/a through 6.3.1.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 8.2)
CVSS3
Base Score: 8.2
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N
IMPACT SCORE
4.2
EXPLOITABILITY
3.9
CVE-2026-105122
SUMMARY

OpenAM before 16.1.3 contains a server-side request forgery vulnerability that allows attackers able to register or modify OAuth 2.0 clients to make OpenAM fetch internal resources via an unvalidated jwks_uri. Attackers can trigger unauthenticated fetches through client-authentication and ID-token validation to probe internal hosts, metadata endpoints or local files, or exhaust request threads for denial of service.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
2.5
EXPLOITABILITY
2.8
CVE-2026-105121
SUMMARY

OpenAM before 16.1.3 contains an improper authorization vulnerability that allows delegated administrators to destroy sessions outside their realms because realm checks use the requester's realm. Authenticated accounts holding the iplanet-am-session-destroy-sessions attribute can supply a target session identifier or handle to forcibly log out users in any realm.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 4.9)
CVSS3
Base Score: 4.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
1.2